Case Studies

IRStrategy

Pre-IPO - IR Infrastructure and Outreach

National, Clinical, Pre-clinical, Public

LaVoie Health Science was tasked with building IR credibility and visibility for a recently public, little known NASDAQ company with a first-of-its-kind technology for inhalable therapeutics to solve a major drug delivery challenge. We needed to support the Company’s efforts to leverage its disruptive technology with commercial industry and governmental partnerships. We worked to establish an external IR department to handle all aspects of investor relations and corporate communications

LHS Solution

  • Implement a “full charge” IR infrastructure program based on best practices to ensure disclosure, transparency and investor confidence
  • Utilize LHS Reach™ to develop an aggressive program to extend TFF’s reach within the institutional investment community – both who participated in the IPO, and other new names to the story
  • Leverage LHS’ extensive capital markets access contact to introduce management to key analysts and bankers

Results

  • Increased awareness of corporate profile and understanding of company’s value proposition
  • Developed new corporate communications assets including a corporate profile video and investor presentation
  • Created and distributed 8 corporate and financial disclosure releases in the span of just 2 months
  • Coordinated more than 30 initial high-value one-on-one meetings with investors and potential business partners
  • Arranged high visibility broadcast interviews with key reporters, further the profile of TFF’s leadership team

Partner with us to build your winning company

Our experienced, multi-disciplined team provides seamless integrated communications, offering strategy consulting, investor and corporate communications and public relations/marketing.